Home › Peripheral T-Cell Lymphoma › Pennsylvania › Philadelphia
Peripheral T-Cell Lymphoma clinical trials in Philadelphia, PA
4 studies for Peripheral T-Cell Lymphoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
RecruitingPhase 1/2
- Research Site, Philadelphia
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecruitingPhase 1/2
- Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Peripheral T-Cell Lymphoma trials in other cities
- Houston, TX9 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Baldwin Park, CA5 studies
- Atlanta, GA4 studies
- Ann Arbor, MI3 studies
- Aurora, CO3 studies
- Columbus, OH3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.